Recently, several medical device companies have launched AI-based imaging diagnostic devices capable of quickly identifying lung nodules, cardiovascular lesions, and early-stage tumors. These devices analyze massive amounts of image data using deep learning algorithms, automatically marking suspicious areas and generating reports, significantly reducing doctors’ diagnostic time and improving accuracy.

With an aging population and rising incidence of chronic diseases, the AI ​​imaging market is growing rapidly. Industry forecasts predict that the global medical AI imaging market will reach $7 billion by 2026, with a compound annual growth rate exceeding 20%.